BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 38514271)

  • 1. Research progress in the metabolic reprogramming of hepatocellular carcinoma (Review).
    Gao W; Wang J; Xu Y; Yu H; Yi S; Bai C; Cong Q; Zhu Y
    Mol Med Rep; 2024 Jul; 30(1):. PubMed ID: 38818815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of lipid metabolism in hepatocellular carcinoma.
    Cheng Y; He J; Zuo B; He Y
    Discov Oncol; 2024 Jun; 15(1):206. PubMed ID: 38833109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular Carcinoma and Lipid Metabolism: Novel Targets and Therapeutic Strategies.
    Cao LQ; Xie Y; Fleishman JS; Liu X; Chen ZS
    Cancer Lett; 2024 Jun; ():217061. PubMed ID: 38876384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression.
    Xu K; Xia P; Gongye X; Zhang X; Ma S; Chen Z; Zhang H; Liu J; Liu Y; Guo Y; Yao Y; Gao M; Chen Y; Zhang Z; Yuan Y
    Mol Metab; 2022 Sep; 63():101540. PubMed ID: 35798238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid metabolism-related long noncoding RNA RP11-817I4.1 promotes fatty acid synthesis and tumor progression in hepatocellular carcinoma.
    Wang RY; Yang JL; Xu N; Xu J; Yang SH; Liang DM; Li JZ; Zhu H
    World J Gastroenterol; 2024 Feb; 30(8):919-942. PubMed ID: 38516243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway.
    Xu M; Zhou C; Weng J; Chen Z; Zhou Q; Gao J; Shi G; Ke A; Ren N; Sun H; Shen Y
    J Exp Clin Cancer Res; 2022 Aug; 41(1):253. PubMed ID: 35986343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research progress of long-chain non-coding RNA in lipid metabolism reprogramming in primary hepatocellular carcinoma].
    Yu Z; Chen DM; Huang JL
    Zhonghua Gan Zang Bing Za Zhi; 2024 Feb; 32(2):180-185. PubMed ID: 38514271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma.
    Liao W; Du J; Wang Z; Feng Q; Liao M; Liu H; Yuan K; Zeng Y
    Int J Cancer; 2022 Aug; 151(3):337-347. PubMed ID: 35460073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging roles and potential clinical applications of long non-coding RNAs in hepatocellular carcinoma.
    Sheng J; Lv E; Xia L; Huang W
    Biomed Pharmacother; 2022 Sep; 153():113327. PubMed ID: 35779423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional roles of lncRNA-TUG1 in hepatocellular carcinoma.
    Farzaneh M; Ghasemian M; Ghaedrahmati F; Poodineh J; Najafi S; Masoodi T; Kurniawan D; Uddin S; Azizidoost S
    Life Sci; 2022 Nov; 308():120974. PubMed ID: 36126725
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.